Kazia Therapeutics annual depreciation and amortization
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Kazia Therapeutics Depreciation & Amortization Growth & History (KZIA)
Kazia Therapeutics's depreciation and amortization was $934,000 for fiscal 2025.
View full Kazia Therapeutics company overviewKazia Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $934,000 | −$935,000 | −50.03% |
| 2024 | 2024-06-30 | $1.9M | $0 | 0.00% |
| 2023 | 2023-06-30 | $1.9M | $0 | 0.00% |
| 2022 | 2022-06-30 | $1.9M | $604,000 | +47.75% |
| 2021 | 2021-06-30 | $1.3M | $181,000 | +16.70% |
| 2020 | 2020-06-30 | $1.1M | $0 | 0.00% |
| 2019 | 2019-06-30 | $1.1M | −$463,000 | −29.93% |
| 2018 | 2018-06-30 | $1.5M | $128,000 | +9.02% |
| 2017 | 2017-06-30 | $1.4M | $776,000 | +120.68% |
| 2016 | 2016-06-30 | $643,000 | — | — |
Kazia Therapeutics depreciation and amortization trends
Over the last five fiscal years, Kazia Therapeutics's depreciation and amortization decreased from $1.1M to $934,000, a change of −$150,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kazia Therapeutics source filings ↗